Page last updated: 2024-12-06

4-chlorophenylhydroxylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-chlorophenylhydroxylamine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID69983
CHEMBL ID150465
SCHEMBL ID2395890
MeSH IDM0070067

Synonyms (30)

Synonym
4-chloro-n-hydroxyaniline
nsc528511
nsc-528511
n-(4-chlorophenyl)hydroxylamine
benzenamine, 4-chloro-n-hydroxy-
n-(p-chlorophenyl)hydroxylamine
nsc166794
nsc-166794
hydroxylamine, n-(p-chlorophenyl)-
4-chlorophenylhydroxylamine
p-chlorophenylhydroxylamine
823-86-9
nsc 528511
ccris 5064
nsc 166794
p-chlorohydroxylaminobenzene
1-chloro-4-hydroxylaminobenzene
4-chlorohydroxylaminobenzene
CHEMBL150465
AKOS006237875
unii-g45nnf2mxz
n-hydroxy-4-chloroaniline
n-hydroxy-4-chloraniline
4-chloro-n-hydroxybenzenamine
g45nnf2mxz ,
n-(4-chlorophenyl)-hydroxylamine
DTXSID20231677
SCHEMBL2395890
1-chloro-4-(hydroxyamino)benzene #
n-(4-chloro-phenyl)hydroxylamine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Parallel GPMT and Buehler tests were conducted according to OECD guideline #406 using a multiple-dose design and test results were analysed using a standard logistic dose-response model."( Comparison of the sensitivities of the Buehler test and the guinea pig maximization test for predictive testing of contact allergy.
Andersen, KE; Frankild, S; Vølund, A; Wahlberg, JE,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
4-chloronitrobenzene degradation620

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1A1 Rattus norvegicus (Norway rat)Km26.00005.00007.571410.0000AID39219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID229377Ratio of kcat/Km determined for catalytic efficiency in sulfonation against AST IV2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID39219Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID39220Maximal velocity (Vmax) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.06 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]